BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38797233)

  • 21. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.
    Cheng B; Yu Q; Wang W
    J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
    Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblasts in cancer: Defining target structures for therapeutic intervention.
    Boesch M; Baty F; Rumpold H; Sopper S; Wolf D; Brutsche MH
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):111-121. PubMed ID: 31265878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment.
    Desbois M; Wang Y
    Immunol Rev; 2021 Jul; 302(1):241-258. PubMed ID: 34075584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A framework for advancing our understanding of cancer-associated fibroblasts.
    Sahai E; Astsaturov I; Cukierman E; DeNardo DG; Egeblad M; Evans RM; Fearon D; Greten FR; Hingorani SR; Hunter T; Hynes RO; Jain RK; Janowitz T; Jorgensen C; Kimmelman AC; Kolonin MG; Maki RG; Powers RS; Puré E; Ramirez DC; Scherz-Shouval R; Sherman MH; Stewart S; Tlsty TD; Tuveson DA; Watt FM; Weaver V; Weeraratna AT; Werb Z
    Nat Rev Cancer; 2020 Mar; 20(3):174-186. PubMed ID: 31980749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.
    Wu F; Yang J; Liu J; Wang Y; Mu J; Zeng Q; Deng S; Zhou H
    Signal Transduct Target Ther; 2021 Jun; 6(1):218. PubMed ID: 34108441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
    Al-Bzour NN; Al-Bzour AN; Ababneh OE; Al-Jezawi MM; Saeed A; Saeed A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment.
    Shalabi S; Belayachi A; Larrivée B
    Front Immunol; 2024; 15():1284629. PubMed ID: 38375479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.
    Liu T; Han C; Wang S; Fang P; Ma Z; Xu L; Yin R
    J Hematol Oncol; 2019 Aug; 12(1):86. PubMed ID: 31462327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
    Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
    Stouten I; van Montfoort N; Hawinkels LJAC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment.
    Xiang X; Niu YR; Wang ZH; Ye LL; Peng WB; Zhou Q
    Cytokine Growth Factor Rev; 2022 Oct; 67():35-48. PubMed ID: 35918210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
    Allam A; Yakou M; Pang L; Ernst M; Huynh J
    Front Immunol; 2021; 12():767939. PubMed ID: 34858425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment.
    Prieto-Fernández L; Montoro-Jiménez I; de Luxan-Delgado B; Otero-Rosales M; Rodrigo JP; Calvo F; García-Pedrero JM; Álvarez-Teijeiro S
    Biomed Pharmacother; 2023 May; 161():114502. PubMed ID: 37002578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
    Suzuki J; Tsuboi M; Ishii G
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of miRNAs in cell signaling of cancer associated fibroblasts.
    Eichelmann AK; Matuszcak C; Hummel R; Haier J
    Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.